Next-Generation Tourniquets Market Global Report 2026

The next-generation tourniquets market size has grown strongly in recent years. It will grow from $0.19 billion in 2025 to $0.21 billion in 2026 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to rising military modernization programs, increasing incidence of traumatic injuries, expanding emergency medical services infrastructure, growing awareness of hemorrhage control techniques, higher adoption of prehospital trauma care equipment.

The next-generation tourniquets market size is expected to see strong growth in the next few years. It will grow to $0.27 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to advancements in smart pressure monitoring technologies, increasing investments in tactical medical equipment, growing disaster preparedness initiatives, expanding adoption in civilian emergency response, rising demand for advanced minimally damaging hemorrhage control devices. Major trends in the forecast period include increasing adoption of one-handed rapid application tourniquets, rising focus on lightweight and ergonomic hemorrhage control devices, expansion of civilian trauma preparedness and bleeding control programs, growing demand for advanced junctional hemorrhage management solutions, standardization of tactical combat casualty care and emergency response protocols.

The increasing prevalence of traumatic injuries is expected to drive the growth of the next-generation tourniquets market in the coming years. Traumatic injuries are physical damages resulting from external forces such as road traffic accidents, falls, workplace incidents, sports-related injuries, or acts of violence, and they often lead to severe bleeding that requires immediate hemorrhage management. The rise in traumatic injuries is mainly attributed to increasing vehicle ownership, accelerated urban development, rising traffic congestion, and greater exposure to high-speed modes of transportation, which together increase the risk of severe accidents. Next-generation tourniquets assist trauma management by facilitating rapid arterial compression, limiting blood loss, enhancing survival outcomes, and lowering the likelihood of irreversible tissue damage during emergency medical response and military trauma care. For instance, in April 2026, according to the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, 68,663 traumatic brain injury (TBI)-related deaths were recorded in the United States in 2023, representing an average of nearly 190 deaths each day. The agency further reported around 214,110 TBI-related hospitalizations, demonstrating the significant impact of traumatic injuries. Therefore, the increasing prevalence of traumatic injuries is contributing to the growth of the next-generation tourniquets market.

The growing recognition of preventable trauma deaths is expected to support the growth of the next-generation tourniquets market going forward. Preventable trauma deaths refer to injury-related fatalities, including those caused by road accidents and uncontrolled bleeding, that could have been avoided through prompt medical care and improved access to emergency healthcare services. Awareness of this issue is rising as healthcare organizations and governments increasingly evaluate avoidable mortality rates as an important indicator of healthcare system effectiveness. Next-generation tourniquets help address this challenge by providing emergency responders and even minimally trained individuals with a quicker and more dependable method to control severe bleeding before patients receive advanced medical treatment. For instance, in November 2025, according to the Organization for Economic Co-operation and Development (OECD), a France-based intergovernmental organization, preventable mortality in the United States was recorded at 217 deaths per 100,000 population, significantly exceeding the OECD average of 145 deaths per 100,000, highlighting the ongoing impact of avoidable injury-related deaths across healthcare systems. Therefore, the growing recognition of preventable trauma deaths is supporting the growth of the next-generation tourniquets market.

Key companies operating in the next-generation tourniquets market are focusing on developing advanced solutions, such as sensor-enabled electronic tourniquets with real-time monitoring and connectivity features, to improve hemorrhage control accuracy and patient outcomes. Sensor-enabled electronic tourniquets are advanced automated tourniquet systems that utilize integrated sensors to continuously monitor limb pressure, blood flow, or occlusion status and automatically regulate cuff pressure to ensure safe and effective vascular occlusion during surgical procedures or emergency care. For example, in April 2025, Auric Innovations, a US-based medical technology company, introduced Tele-TQ, its next-generation tourniquet developed on smart telemedicine technology. The device integrates an AI-enabled wearable sensor that monitors blood pressure, heart rate, and oxygen saturation and transmits this data to emergency medical services for faster triage, along with GPS and cellular connectivity that supports two-way communication and real-time location tracking during trauma situations.

Major companies operating in the next-generation tourniquets market report are Zimmer Biomet Holdings Inc., ViTAC Solutions LLC, Rudolf Riester GmbH, SAM Medical Products, Aero Healthcare Pty Ltd, Rescue Essentials LLC, WASIP Ltd., VBM Medizintechnik GmbH, Hunan ShineArk Medical Technology Co. Ltd., Narang Medical Limited, RevMedx Inc., Chinook Medical Gear Inc., Anetic Aid Limited, DiaMedical USA, GPC Medical Ltd., Advin Health Care, Apothecaries Sundries Manufacturing Co. Pvt. Ltd., Prasaditi Medical Equipment Pvt. Ltd., Medilivescare Manufacturing Pvt. Ltd., DS Medical Co. Ltd., Medi Electronics, DAESUNG MAREF Co. Ltd., Hospital Equipment Manufacturing Company (HEMC), Dessillons & Dutrillaux S.A., Doctroid India Private Limited, AGM Orthopaedics, Girish Surgical Works.

North America was the dominant region in the next-generation tourniquets market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the next-generation tourniquets market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the next-generation tourniquets market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.